# Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/direct-medical-costs-of-end-stage-kidney-disease-and-renal-replacement-therapy-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hui Zhang,Chao Zhang,Sufen Zhu,Hongjian Ye,Donglan Zhang |
| Citations | 39 |
| DOI | 10.1186/s12913-020-4960-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/s12913-020-4960-x.pdf |
| OpenAlex ID | https://openalex.org/W3007494676 |
| PMID | 32059726 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Hongjian Ye](https://scholariq.org/researchers/hongjian-ye/)

## Paper journal

- [BMC Health Services Research](https://scholariq.org/journals/bmc-health-services-research/)

## Paper primary topic

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Paper topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.